A detailed history of Sandler Capital Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sandler Capital Management holds 2,000 shares of MRK stock, worth $196,100. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,000
Previous 2,000 -0.0%
Holding current value
$196,100
Previous $247,000 8.1%
% of portfolio
0.03%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $200,360 - $218,040
2,000 New
2,000 $218,000
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $263,772 - $297,636
-3,400 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $230,472 - $269,247
-3,300 Reduced 49.25%
3,400 $285,000
Q1 2019

May 15, 2019

BUY
$69.58 - $79.36 $34,790 - $39,680
500 Added 8.06%
6,700 $557,000
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $404,487 - $469,401
6,200 New
6,200 $474,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Sandler Capital Management Portfolio

Follow Sandler Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandler Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Sandler Capital Management with notifications on news.